Diagnostics and treatment improving of functional ovarian cysts

Authors

DOI:

https://doi.org/10.18370/2309-4117.2015.25.14-20

Keywords:

functional ovarian cysts, phytotherapy, mastodynon

Abstract

Functional ovarian cysts are benign tumour retention formations formed from the natural structures of the ovary – follicle or yellow body. In 50% of cases cysts are asymptomatic and self-liquidated. In the absence of functional cyst self-destruct in the first menstrual cycle after treatment it should be revealing.

Functional cysts are divided into follicular cysts, corpus luteum cyst, paraovarian cysts.

Diagnosis consists of analysing history, general examination, gynaecological examination, clinical laboratory tests (including advanced analysis of blood, determination of C-reactive protein, appropriate biochemical if it need, compulsory bacterioscopic and bacteriological examination of vaginal discharge) and special methods of diagnosing ovarian tumors (ultrasound, computed or magnetic resonance tomography, determination of tumor markers, human chorionic gonadotropin, α-fetoprotein, hormones analysis, endoscopy).

Clinical management of patients with functional cysts in reproductive and perimenopausal age includes the following options. In asymptomatic disease in three menstrual cycles conducted surveillance of ultrasound control and preventive measures against cyst recurrence. Conservative treatment is used after determining the causes of disease for persistent cysts. Therapeutic measures include anti-inflammation therapy, hormonal and anti-adhesion therapy. While cysts maintaining after conservative treatment for three menstrual cycles the laparoscopy is used for removing formations.

Treatment is more successful when combined allopathic, homeopathic and phytotherapy. Most pathogenic provided in the treatment of functional ovarian cysts is an herbal preparation mastodynon. Mastodynon is a complex drug containing standardized herbal ingredients with depressing effect on inflammatory cytokines, helps eliminate hormonal imbalance caused by hyperestrogenia of follicular cysts (endometrial hyperplasia). In addition, the main component of mastodynon – Vitex Agnus Castus – promotes the elimination of the latent hyperprolactinemia, which in turn causes the hyperestrogenia development.

After the disappearance of the cyst to prevent recurrence of reproductive age with elevated levels of follicle stimulating hormone and luteinizing hormone the use of combined oral contraceptives for four to six menstrual cycles is needed.

Surgery treatment indicated if there is complication (torsion, rupture, suppuration).

Author Biography

Т. В. Герасимова, National Medical Academy of Postgraduate Education named after P.L. Shupik

PhD, Honored Doctor of Ukraine, assistant professor of the Obstetrics and Gynecology Department number 1

References

  1. Bohman, Y.V. Oncogynecology Guidelines. St. Petersburg. Foliant (2002): 195–209.
  2. Gynecology of childhood and adolescence: a textbook / Ed. by I.B. Vovk, O.M. Yuzko, V.P. Vdovychenko. Kyiv. Medicine (2011): 424 p.
  3. Gurkin, Y.A. Adolescent Gynecology. St. Petersburg. Foliant (2000): 573 p.
  4. Podzolkova, N.N., Glazkova, O.L. The study of hormonal status of women in the practice of the gynecologist. Moscow. MEDpress- Inform (2004): 80 p.
  5. Serov, V.N., Prilepskaya, V.N., Ovsyannikova, T.V. Gynecological endocrinology. Moscow. MEDpress-Inform (2008): 528 p.
  6. Hachkuruzov, S.G. Ultrasound in Gynecology. Symptoms, diagnostic difficulties and mistakes. St. Petersburg. ELBISPb (2012): 672 p.

Downloads

Published

2015-10-25

How to Cite

Герасимова, Т. В. (2015). Diagnostics and treatment improving of functional ovarian cysts. REPRODUCTIVE ENDOCRINOLOGY, (25), 14–20. https://doi.org/10.18370/2309-4117.2015.25.14-20

Issue

No. 25 (2015)

Section

Gynecology

License

Copyright (c) 2015 Т. В. Герасимова

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

    1. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.